BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 26, 2001
View Archived Issues
Phase II trial of TH-9507 in type 2 diabetes cleared by FDA
Read More
NeuroSearch offers interim progress report
Read More
Hemosol given green light to proceed with Hemolink clinical program
Read More
FDA approval for Genesis IPG Spinal Cord Stimulator system
Read More
Rebetol receives Japanese approval for use in combination with Intron A for hepatitis C
Read More
AASLD news: Gilead's adefovir dipivoxil improves liver function and reduces viral load in HBV
Read More
Design and biological activity of new camptothecin glycoconjugates described by Bayer
Read More
Accelerated progress marks Q3 at Xenova
Read More
Primary endpoint of large tifacogin trial in sepsis patients not met according to Chiron
Read More
Specific activation of amygdala neurons and brain penetration demonstrated for secretin
Read More
Interim report shows British Biotech continues to make good progress
Read More
Preclinical data support use of dexanabinol in neuroinflammatory disorders
Read More
Antimalarial prodrugs in development at Jacobus
Read More
Successful human somatic cell nuclear transfer and parthenogenesis
Read More
Second conference on neuroimmunophilins held during SFN meeting
Read More
Abbott continues to pursue highly selective ETA receptor antagonists
Read More
Introduction of SynX's diagnostic aid for Alzheimer's disease
Read More
M-55113: an anticoagulant factor Xa inhibitor designed at Mochida
Read More
New product significantly reduces the risk of AMD
Read More
Abbott's acquisition of Vysis clears antitrust review
Read More
Specific inhibition of MMP-2 binding to alphavbeta3 integrin for inhibiting angiogenesis
Read More
Antitumor sulfonamide derivatives reported in recent patent by Sankyo
Read More
Protein tyrosine kinase inhibitors from AHP exert antitumor activity in vitro
Read More
Lactam inhibitors of Abeta peptide and their use in Alzheimer's disease and related disorders
Read More
ADIR prepares inhibitors of monoamine reuptake for CNS disorders
Read More
New gastric antisecretory agents designed by Byk Gulden
Read More